PD-1 INHIBITOR
Clinical trials for PD-1 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITOR trials appear
Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gut bacteria boosts cancer fight? new trial tests probiotic combo
Disease control OngoingThis early-stage study tests whether a probiotic called Akkermansia, taken with an immunotherapy drug, is safe for people with advanced colorectal cancer that hasn't responded to standard treatments. The trial involves 22 participants and will monitor side effects, tumor response…
Matched conditions: PD-1 INHIBITOR
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 10:01 UTC
-
New radiation combo aims to boost immunotherapy in hard-to-treat lung cancer
Disease control OngoingThis early-phase study tests whether adding low dose radiation and focused radiation (SBRT) to immunotherapy can be safe for people with advanced non-small cell lung cancer who have run out of standard options. Nine participants will receive the combination treatment at one hospi…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 26, 2026 10:00 UTC
-
New drug combo shows promise for advanced throat cancer
Disease control OngoingThis study tests whether adding a PD-1 inhibitor (a type of immunotherapy) to chemotherapy before standard treatment can help people with advanced nasopharyngeal cancer. About 150 participants will receive either the drug combo or standard care. The main goal is to see if the com…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC